Pulmocide

London, United Kingdom · Founded 2007 · Privately Held (backing)

Developer of antifungal drugs designed to treat acute and chronic respiratory diseases. Pulmocide is based in London, United Kingdom and was founded in 2007. Its last reported valuation was $292 million in Sep 2025. It has raised $268 million.

Last reported valuation

$291.6M

Oct 2026

Priced at

—

Total raised

$267.6M

Last round

—

How much has Pulmocide raised?

$267.6Macross 0 recorded rounds

Free account

More of Pulmocide with a free account

·The complete investor list: 15 names
·Watch Pulmocide: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Pulmocide investors

15 investors are on record for Pulmocide, including F-Prime Capital, Eight Roads, Johnson & Johnson JJDC and SV Health Investors. By type, the record holds 4 venture capital firms and 2 asset managers.

For fundraisers

Raising for a company like Pulmocide?

15 investors have backed Pulmocide.

See all 15 investors →

Frequently asked about Pulmocide

How much has Pulmocide raised?: Pulmocide has raised $267.6M in total across 0 recorded funding rounds.